Share of hypertension market India FY 2020, by drug class

Published by A. Minhas, Jul 12, 2023
The hypertension drug class Angiotensin had the highest market share in the cardiac market of about 22 percent in financial year 2020. It was worth about 41 billion Indian rupees that year. Beta Blockers had the second highest market value among the drug classes in hypertension that year.

Share of hypertension market across India in financial year 2020, by drug class

CharacteristicMarket share
Diuretics 4%
Calcium Channel Blockers 13.5%
Beta Blockers 16.7%
Angiotensin 22.7%
Showing entries 1 to 4 (4 entries in total)
Created with Highcharts 7.2.2Market share4%4%13.5%13.5%16.7%16.7%22.7%22.7%DiureticsCalcium Channel BlockersBeta BlockersAngiotensin
0%5%10%15%20%25%

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2020

Region

India

Survey time period

FY 2020

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2020 started in April 2019 and ended in March 2020.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom

Related reports: Available to download in PDF or PPTX format

All datain one format
All data
in one format
Cardiovascular disease in India
  • 42 page/s
  • English
  • pptx
  • Detailed references

Everything on "Cardiovascular disease in India" in one document: edited and divided into chapters, including detailed references.

Go to report
Further reports
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Cardiovascular disease in India "

Other statistics that may interest you Cardiovascular disease in India

Overview

5

Heart disease

5

Hypertension

4

Leading cardiac therapies

4

Leading cardiac brands and molecules

7

Leading market players

7

Further related statistics

18

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

Cardiovascular disease in IndiaCardiovascular disease in the U.S.Cardiovascular disease in the UK
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.